Cited by 365T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmune Response and Inflammation

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

PD-1 is a novel regulator of human B-cell activation

Thibult, Marie-Laure, Mamessier, Emilie, Gertner-Dardenne, Julie, Pastor, Sonia, Just-Landi, Sylvaine, Xerri, Luc, Chetaille, Bruno, Olive, Daniel·2013·International Immunology

DOI 10.1093/intimm/dxs098

Open this paper in CoChat — free account

Abstract

The outcome of the adaptive immune response is determined by the integration of both positive and negative signals, respectively, induced upon the triggering of co-signaling receptors. One of them, programmed cell death 1 (PDCD1/PD-1) has largely been shown to be involved in the negative regulation of T-cell activation. However, PD-1 is also expressed on human B cells, and its role(s) in the process of human B-cell activation remains uncertain thus far. In this study, we describe the expression of PD-1 on the major human B-cells subsets isolated from peripheral blood and lymph nodes. We showed that PD-1 was expressed on naive B cells, was differentially expressed on peripheral IgM memory as compared with memory B cells and was lost on germinal center B cells. Expression of PD-1 ligands (PD-Ls) was induced by TLR9 activation. Finally, we showed that PD-1 was recruited to the B-cell receptor upon triggering. We determined that during TLR9 activation, blockade of PD-1/PD-Ls pathways indeed increased B-cell activation, proliferation and the production of inflammatory cytokines. Altogether, our results show, that, as reported in T cells, PD-1/PD-Ls complexes acted as inhibitors of the B-cell activation cascade and highlight the importance of devising future therapies able to modulate lymphocyte activation through the targeting of the PD-1/PD-Ls pathways.

Integrity signals

Registry

Crossref · 10.1093/intimm/dxs098

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,259
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,785
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubat, T., Yagita, H., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.765 · Cited by 1,589
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611533104 · Cited by 1,378

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Sorted by citations

Items 301–365 of 365

Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers
Saleh, Z., Mehdipour, F., Ataollahi, M. R., Ali‐Hassanzadeh, M., Kabelitz, D., & Kalantar, K. (2023) · Current Microbiology · doi:10.1007/s00284-023-03367-0 · Cited by 1
Influence of Different Nicotine Sources on Exercise-Driven Immune Responses of Peripheral Blood Monocytes
Axt, P. N., Mohr, T., Steffen, A., Plötze‐Martin, K., Jagodzinski, N., Bohnet, S., Drömann, D., Bruchhage, K., Franzen, K. F., & Pries, R. (2025) · Toxics · doi:10.3390/toxics13060472 · Cited by 1
Immune Modulatory Effects of PD ‐1/ PD ‐ L1 in Myasthenia Gravis: Insights From Peripheral Blood Mononuclear Cell Analysis
Li, J., Liu, X., Qi, F., Ren, Y. X., Zhang, Y., Shen, Y., Liu, H., Wang, Y., Zheng, R., Ou, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500887r · Cited by 1
Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer
Isoda, B., Shiga, M., Kandori, S., Takahashi, S., Omiya, A., Ishida, T., Matsuda, K., Sakurai, H., Mathis, B. J., Tanaka, K., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0337 · Cited by 1
B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma
Liljeström, V., da Silva, P. F. N., Bark, R., Elliot, A., Marklund, L., Margolin, G., Georén, S. K., Cardell, L., & Piersiala, K. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04231-9 · Cited by 2
B-cell–directed Immunotherapy for Solid Tumors
Anderko, R. R., Tcharni, A., Zureikat, A. H., & Bruno, T. C. (2026) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2025.10.009 · Cited by 1
Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms
Sherief, D., Nosair, N. A. E.-A., Abdelhameed, A. M., Sadaka, E., Othman, A. A. A., & Elgamal, R. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i1.112801 · Cited by 1
Humoral immunity in cancer
Leonard, J., Duhamel, M., & Salzet, M. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02902-2 · Cited by 2
Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
Welch, B. M., Manso, B. A., Gwin, K. A., Lothert, P. K., Parikh, S. A., Kay, N. E., & Medina, K. L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1302038 · Cited by 1
PD-1 and LAG-3 as early prognostic markers in the treatment of patients with chronic lymphocytic leukemia
Selyutina, O. N., Лысенко, И. Б., Guskova, N. K., Novikova, I. A., Zlatnik, E. Y., Pushkareva, T. F., Nikolaeva, N. V., Анатольевна, К. И., Kapuza, E. A., Сулеймановна, Г. Я., et al. (2023) · Oncohematology · doi:10.17650/1818-8346-2023-18-4-156-162 · Cited by 1
A case of coagulation factor V inhibitor induced by immune checkpoint inhibitor therapy
Haruta, Y., Azuma, M., Sado, T., Saito, R., Miyazaki, Y., Noda, A., Kitagawa, R., Hori, Y., Fujimoto, S., Hasegawa, Y., et al. (2024) · Respirology Case Reports · doi:10.1002/rcr2.1307 · Cited by 1
Alpha-fetoprotein upregulates hepatocellular carcinoma cell-intrinsic PD-1 expression through the LATS2/YAP/TEAD1 pathway
Leng, G., Gong, H., Liu, G., Kong, Y., Guo, L., & Zhang, Y. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130592 · Cited by 1
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform
Alles, M., Gunasena, M. G. B., Isckarus, C., Silva, I. D., Sarah Board, Mulhern, W., Collins, P. L., Demberg, T., & Liyanage, N. P. M. (2025) · npj Vaccines · doi:10.1038/s41541-024-01053-1 · Cited by 1
Immunological Synapse in the Biology of Chronic Lymphocytic Leukemia
Badmazhapova, D. S., Galtseva, I. V., & Zvonkov, E. E. (2018) · Clinical oncohematology · doi:10.21320/2500-2139-2018-11-4-313-318 · Cited by 1
Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia
Jamali, A., Nemovi, K., Kaur, J., & Dasanu, C. A. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221074025 · Cited by 1
Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients
Zegallai, H. M., & Hatch, G. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-10270-4 · Cited by 1
Cellular Interactions Occurring in the Hilar Lymph Node Mediate the Development of Tolerance in an Ovalbumin - Induced Murine Model of Allergic Airway Disease
Natarajan, P. (2013) · OpenCommons at University of Connecticut (University of Connecticut)
Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung
Bartkowiak, T. (2013) · Digital Commons-TMC (Texas Medical Center)
Évaluation de l'expression et de la valeur pronostique de PD-L1 dans les cancers colorectaux traités par chirurgie première : série rétrospective de 105 cas
Cogniet, G. (2016) · HAL
Assoziation des PDCD1 rs11568821 GG-Genotyps mit stärkerer Morbidität bei Intensivpatienten mit Krankheitsbild Sepsis: Vergleich der SOFA-Sub-Scores
Gerber, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5678
The response of genes and pathways of immunological system induced by irradiationPreprint
Ribeiro, F. M., Silveira, D. A., Simão, É. M., de Mattos, V. L. D., & de Góes, E. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/526384
Análise da função supressora das células T reguladoras em episódios reacionais hansênicos
Lobo, C. C. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-06082019-124326
Immune checkpoint inhibitor induced autoimmune encephalitis in a patient with metastatic melanoma
Sudhekar, N., Yohannan, B., & Feldman, M. L. (2020) · Case Reports in Internal Medicine · doi:10.5430/crim.v7n3p1
Immunity and Protection against Human Metapneumovirus
Wen, S. C. (2015)
Genome-scale Pathway Flux Analysis Predicts Efficacy of anti-PD-1 Therapy in MelanomaPreprint
Mei, Q., Du, S., Halfter, K., Li, X., Zhang, G., Li, Y., Saad, C., Huang, H., Qi, S., Cheng, W., et al. (2020) · doi:10.21203/rs.3.rs-18122/v1
Aberrant expression of PD-1 on B cells and their subpopulations in systemic lupus erythematosus and association with clinical parametersPreprint
Xie, C., Yang, L., Zhu, Q., Li, Y., Wang, Q., Jiang, C. Q., Li, Z., Wang, H., Wang, Y., Zhang, W., et al. (2019) · doi:10.21203/rs.2.17942/v1
Avaliação da expressão e função de PD-1 e seu ligante PD-L1 nas subpopulações de linfócitos B em pacientes com imunodeficiências comum variável (ICV) com infecções de repetição
Santos, B. A. N. (2021) · doi:10.11606/t.5.2021.tde-09082021-114403
Avaliação da expressão e função de PD-1 e seu ligante PD-L1 nas subpopulações de linfócitos B em pacientes com Imunodeficiência Comum Variável (ICV) com manifestações gastr
Zilinski, F. R. (2021) · doi:10.11606/d.5.2021.tde-09092021-104352
Development and validation of diagnostic and pharmacodynamic cancer biomarker methods and their (pre)clinical application
Pluim, D. (2021) · doi:10.33540/900
Immunopharmacogenomics: a hope in the treatment of carcinoma
Bilquees, Jeelani, H., Tabasum, N., & Pottoo, F. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00011-7
Avaliação imunofenotípica, funcional e gênica de subpopulações de células B em pacientes com esclerose sistêmica submetidos ao transplante autólogo de células-tronco hematopoiética
Júnior, J. R. L. (2019) · doi:10.11606/t.60.2019.tde-27102021-123822
Severe Rashes Associated With Immunotherapy and Gene Mutations in a Patient With Metastatic Pancreatic CancerPreprint
Ye, Y., & Zheng, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1374816/v1
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Geladaris, A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9057
Faculty Opinions recommendation of Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Yu, S. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734524589.793567572
References
(2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812896-1.00040-4
Cutaneous Toxic Effects in tumor patients treated with Programmed Cell Death Protein-1 checkpoint inhibitors and/or Programmed Death-Ligand 1 checkpoint inhibitors and its association with survival: a systematic review and meta-analysisPreprint
Zhao, F., Zhu, J., Shao, T., Chen, S., Zhang, G., & Shu, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1601395/v1
Circulating B Cells in Relapsing-Remitting Multiple Sclerosis Show Markedly Different Patterns of Regulatory Marker Expression Compared with Healthy ControlsPreprint
Mielcarz, D. W., Bergeron, A. J., DeLong, J. K., Dias, A., Smith, K. M., Mack, K. L., Kasper, L. H., & Channon, J. Y. (2022) · medRxiv · doi:10.1101/2022.08.30.22279393
Research progress on mechanisms and predictive biomarkers for immune-related adverse eventsPreprint
Zhang, Y., Qu, Z., Zhang, T., Zhao, Z., Zhang, Y., & Gu, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2494743/v1
Novel Blood-Based RNA Profiles can Predict Human Degenerative Cervical MyelopathyPreprint
Zheng, Z., Chen, J., Xu, J., Jiang, B., Dai, Y., Li, L., Li, Y., & Wang, B. (2023) · Research Square · doi:10.21203/rs.3.rs-2342505/v1
Unveiling the Immune Dynamics of Neisseria Persistent Oral Colonization: A Roadmap for Innovative Vaccine StrategiesPreprint
Alles, M., Gunasena, M. G. B., Zia, T., D’Mello, A., Bhattarai, S. S., Mulhern, W., Terry, L., Scherger, T., Wijeratne, S., Singh, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.18.572139
Triggers for autoimmunity
Wagner, C. A., Smith, K., James, J. A., & James, E. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00025-4
Comparative impact of porcine reproductive and respiratory virus and swine influenza A virus infections on respiratory lymph nodes B cells and macrophagesPreprint
Hervet, C., Perrin, A., Renson, P., Deblanc, C., Muñoz, M., Meurens, F., Argilaguet, J. M., Simon, G., Bourry, O., Maisonnasse, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617816
Optimization of anti-LAG-3 antibody: A comprehensive computer study
Wu, L. (2024) · International Symposium on Artificial Intelligence for Medicine Sciences (ISAIMS) · doi:10.1145/3706890.3707017
PDCD1 expression increases at elevated temperatures
Toma-Jonik, A., Janus, P., Mrowiec, K., Vydra, N., Sarkowicz, K., Bar, M., Mirek, J., Olbryt, M., Fidyk, W., & Widłak, W. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102314
Additional file 2 of Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
Zhou, X., Yao, Z., Yang, H., Liang, N., Zhang, X., & Zhang, F. (2020) · Figshare · doi:10.6084/m9.figshare.12154011
Additional file 1 of A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
Wu, C.-T., Chu, C.-I., Wang, F.-Y., Yang, H.-Y., Tseng, W.-S., Chang, C.-R., & Chang, C.-C. (2022) · Figshare · doi:10.6084/m9.figshare.21256882
Additional file 1 of Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
Zhou, X., Yao, Z., Yang, H., Liang, N., Zhang, X., & Zhang, F. (2020) · Figshare · doi:10.6084/m9.figshare.12153999
Comparative Immunology
Bracha, S., & Pollack, S. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-04454-9_4
Identification of Immune&Driver Molecular Subtypes Optimizes Immunotherapy Strategies for Gastric Cancer
Gan, J., Yang, B., Wang, S., Zhu, H., Xu, M., Xu, Y., Li, X., Dong, W., Zhao, Y., Liu, M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020696
Adaptive immune and platelet activation during the maintenance phase of therapy in adults with B cell acute lymphoblastic leukemia
Mkhwanazi, Z. A., Nyambuya, T. M., Shingenge, E., & Nkambule, B. B. (2026) · Platelets · doi:10.1080/09537104.2026.2636463
Imbalanced immune cell network and suboptimal cell activation: signatures associated with disease severity in vaccine-naïve COVID-19 patients
Ocaña‐Guzmán, R., Pitén-Isidro, E., Flores‐González, J., Ramón‐Luing, L. A., Estrada, P. M. D. R., Falfán‐Valencia, R., Pérez-Rubio, G., Buendía-Roldán, I., Selman, M., & Chávez‐Galán, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1794103
Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective?
Cho, H. S., & Lee, S. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062680
Parodontite et inflammation : approche clinique et biologique du rôle du lymphocyte B
Demoersman, J. (2018) · doi:10.70675/a2f00157z9b58z4916z98e8zf3a7feecb427
CD28 : nouvelles données sur un récepteur majeur de la costimulation lymphocytaire T
Morin, S. O. (2017) · theses.fr (ABES) · doi:10.70675/cb01635fz2f63z43e2zad0cz210485c4c5cf
Le récepteur co-inhibiteur BTLA au cours du lupus érythémateux disséminé (LED) : aspects fondamentaux et implications thérapeutiques
Sawaf, M. (2018) · theses.fr (ABES) · doi:10.70675/eaf792a1zb140z4edcz9257ze075f23bca45
Etude des syndromes lymphoprolifératifs lymphocytaires T induits par un dysfonctionnement de l'adaptateur moléculaire LAT
Joachim, A. (2021) · theses.fr (ABES) · doi:10.70675/e6219312z1b66z4f26z9cb6z7577451dfe70
Etude de l’hétérogénéité des centrocytes humains à travers l’expression du CD23 : différenciation en plasmablastes et expression d’une signature minimale transcriptionnelle au niveau cellule-unique comportant DEC2
Santamaria, K. (2020) · theses.fr (ABES) · doi:10.70675/0550da9bz6935z43d6z9117z2f2fdffb714c
Caractérisation transcriptomique des cellules lymphoïdes innées
Crinier, A. (2020) · theses.fr (ABES) · doi:10.70675/850e38aazc227z4187z9c41z07c47cac00d9
Thérapies du cancer de nouvelle génération et fonctions cognitives : Nouveaux concepts, nouveaux mécanismes, biomarqueurs originaux.
Coppola, N. (2023) · theses.fr (ABES) · doi:10.70675/0eaeed03z4d50z4014z947czedd9a2ec2c91
Etude de l'hétérogénéité du microenvironnement et des cellules tumorales dans le lymphome TFH
Mboumba, D. L. (2024) · theses.fr (ABES) · doi:10.70675/ab609d7azbd90z40daza2b9za9670f82c1f5
B lymphocytes and autoantibodies in immune-related adverse events following immune checkpoint inhibitors in cancer patients
Soussan, S. (2024) · theses.fr (ABES) · doi:10.70675/37eaf5e6z0c22z40a6z8173zfc4a1897db15
Clinical Features, Treatment, and Outcomes of Nivolumab-induced Autoimmune Hemolytic Anemia
Liu, M., Kong, L., Sun, W., Pan, Y., & Wang, C. (2026) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000612
Malaria exposure history shapes PD-1 expression across human B-cell subsets during acute Plasmodium falciparum infection
Mortazavi, S. E., Lugaajju, A., Tijani, M. K., Wu, B., Danielsson, L., Norrgren, H., & Persson, K. E. M. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05388-8
Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact
Vezyrgiannis, K., Macleod, E., Nutley, A. S., Zhu, Y., & Denton, A. E. (2026) · Aging Cell · doi:10.1111/acel.70766
PD-L1 expression in germinal centers promotes humoral immunity by restricting T follicular regulatory cell differentiation
Akama‐Garren, E. H., Zhang, Y., Heesters, B. A., Fallon, P. G., & Carroll, M. C. (2026) · Immunity · doi:10.1016/j.immuni.2026.10.001

Authors: Thibult, M.-L., Mamessier, E., Gertner-Dardenne, J., Pastor, S., Just-Landi, S., Xerri, L., Chetaille, B., & Olive, D.
Affiliations: Inserm (FR)
Centre de Recherche en Cancérologie de Marseille (FR)
ORCID: Pastor, Sonia
Xerri, Luc
Olive, Daniel
Venue: International Immunology
Publisher: Oxford University Press (OUP)
Published: 2012-10-18
Volume: 25
Issue: 2
Pages: 129-137
ISSN: 0953-8178 (ISSN-L)
1460-2377
DOI: 10.1093/intimm/dxs098
OpenAlex: W2131640081
Cited by: 365
References: 45
Citations by year: 2026: 16 · 2025: 28 · 2024: 38 · 2023: 25 · 2022: 44 · 2021: 43 · 2020: 47 · 2019: 38 · 2018: 27 · 2017: 20 · 2016: 19 · 2015: 8 · 2014: 8 · 2013: 4
FWCI: 2.79
Type: journal article
Language: en
Open access: closed
Locations: International Immunology (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords: PD-1, PD-L1, PD-L2, B cell activation, B cell receptor signaling, TLR9, naive B cells, memory B cells, germinal center B cells, B cell proliferation, inflammatory cytokines
MeSH terms: B-Lymphocytes, Humans, Lymphocyte Activation, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PD-1 is a novel regulator of human B-cell activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks